Almost nothing. That is a few weeks of global medical R&D spend, spread over more than a decade.
Annual R&D spending of pharmaceutical companies:
Merck - $17.9B
Johnson & Johnson - $17.2B
Roche - $14.6B
AstraZeneca - $13.6B
AbbVie - $12.8B
Bristol Myers Squibb - $11.2B
Eli Lilly - $10.99B
Meta’s losses on Metaverse last year - $19.2B
So, simply redirecting their spending in that division would instantly propel Meta to be the biggest medical researcher in the world. And as a bonus they’d get a real return out of it.
It would cover the entire NIH budget for two years. That isn't nothing.
Annual R&D spending of pharmaceutical companies:
Merck - $17.9B
Johnson & Johnson - $17.2B
Roche - $14.6B
AstraZeneca - $13.6B
AbbVie - $12.8B
Bristol Myers Squibb - $11.2B
Eli Lilly - $10.99B
Meta’s losses on Metaverse last year - $19.2B
So, simply redirecting their spending in that division would instantly propel Meta to be the biggest medical researcher in the world. And as a bonus they’d get a real return out of it.